Academic Collaborations
We’ve worked with colleagues at home and abroad to deliver outstanding academic research projects.
Our academic research collaborations range from the development and characterisation of novel compounds, to high throughput screening and quantitative imaging. In addition, we maintain our commitment to leadership in the field of drug discovery research through work with professional associations. Here is a sampling of some of our recent collaborative work in academia:
Novel Compounds and Delivery Systems
Genomic, proteomic and metabolic characterisation of novel organometallic compound [Os(η(6)-p-cymene)(4-(2-pyridylazo)-N,N-dimethylaniline
Professor Peter Sadler, University of Warwick, United Kingdom
Access this publication at the National Center for Biotechnology Information website.
Synthesis of 6,8,9 Poly-substituted Purine Analogue Libraries as Pro-Apoptotic Inducers of Human Leukemic Lymphocytes and DAPK-1 Inhibitors
Professor Ignacio Molina and Dr Juan José Díaz-Mochón, Universidad de Granada, Spain
Access this publication at the National Center for Biotechnology Information website.
Extracellular Palladium-Catalysed Dealkylation of 5-Fluoro-1-Propargyl-Uracil as a Bioorthogonally Activated Prodrug Approach
Dr Carmen Torres-Sánchez, Loughborough University, United Kingdom
Access this publication at the National Center for Biotechnology Information website.
Synthesis of Polystyrene Microspheres and Functionalization with Pd0 Nanoparticles to Perform Bioorthogonal Organometallic Chemistry in Living Cells.
Professor Rosario Sanchez-Martin, GENyO, Pfizer-University of Granada-Junta de Andalucia, Granada, Spain
Access this publication at the National Center for Biotechnology Information website.
Assays and Screening
A Yeast Chemical Genetic Screen Identifies New Inhibitors of Human Telomerase
Professor Lea Harrington, GENyO, Institute for Research in Immunology and Cancer of the University of Montreal, Canada
Access this publication at the National Center for Biotechnology Information website.
Mechanism of Action Studies
Ret inhibition mechanism-of-action studies in breast cancer
Professor Nancy Hynes, Friedrich Miescher Institute for Biomedical Research (FMI), Basel, Switzerland.
Access this publication at the National Center for Biotechnology Information website.
Drug mechanism–of-action studies in Gioblastoma models
Dr Andrew Westhoff, University of Ulm, Germany
Access this publication at the National Center for Biotechnology Information website.
Imaging
High content image-informatics
Professor Anne Carpenter, Broad Institute and MIT, USA
Access this publication at the National Center for Biotechnology Information website.
Quantitative imaging in complex in vitro and in vivo models.
Dr Paul Timpson, Garvan Institute, Sydney, Australia
Access this publication at the National Center for Biotechnology Information website.
Contributions to Best Practice
Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research
Global RPPA Society
Access this publication at the National Center for Biotechnology Information website.
European Cell based Assay Interest Group: Advancing Cell Based Assay Sciences.
Read more on the European Cell based Assay Interest Group website.
The National Phenotypic Screening Centre, University of Dundee, United Kingdom
Visit the National Phenotypic Screening Centre website.
Read about our industry collaborations